Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Surgery Plus Intraoperative Photodynamic Therapy (PDT) in Patients With Resectable, Primary or Recurrent Head and Neck Cancer

NCT00470496 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT00470496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00470496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Surgery Plus Intraoperative Photodynamic Therapy (PDT) in Patients With Resectable, Primary or Recurrent Head and Neck Cancer
Lead sponsor
Roswell Park Cancer Institute
Phase
Phase 1
Overall status
Completed
Start date
October 19, 2006
Completion date
August 30, 2018
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent adenoid cystic carcinoma of the oral cavity, recurrent basal cell carcinoma of the lip, recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity, recurrent inverted papilloma of the paranasal sinus and nasal cavity, recurrent lymphoepithelioma of the nasopharynx, recurrent lymphoepithelioma of the oropharynx, recurrent metastatic squamous neck cancer with occult primary, recurrent midline lethal granuloma of the paranasal sinus and nasal cavity, recurrent mucoepidermoid carcinoma of the oral cavity, recurrent salivary gland cancer, recurrent squamous cell carcinoma of the hypopharynx, recurrent squamous cell carcinoma of the larynx, recurrent squamous cell carcinoma of the lip and oral cavity, recurrent squamous cell carcinoma of the nasopharynx, recurrent squamous cell carcinoma of the oropharynx, recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity, recurrent thyroid cancer, recurrent verrucous carcinoma of the larynx, recurrent verrucous carcinoma of the oral cavity, stage i adenoid cystic carcinoma of the oral cavity, stage i basal cell carcinoma of the lip, stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity, stage i follicular thyroid cancer, stage i inverted papilloma of the paranasal sinus and nasal cavity, stage i lymphoepithelioma of the nasopharynx, stage i lymphoepithelioma of the oropharynx, stage i midline lethal granuloma of the paranasal sinus and nasal cavity, stage i mucoepidermoid carcinoma of the oral cavity, stage i papillary thyroid cancer, stage i salivary gland cancer, stage i squamous cell carcinoma of the hypopharynx, stage i squamous cell carcinoma of the larynx, stage i squamous cell carcinoma of the lip and oral cavity, stage i squamous cell carcinoma of the oropharynx, stage i squamous cell carcinoma of the paranasal sinus and nasal cavity, stage i verrucous carcinoma of the larynx, stage i verrucous carcinoma of the oral cavity, stage ii adenoid cystic carcinoma of the oral cavity, stage ii basal cell carcinoma of the lip, stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity, stage ii follicular thyroid cancer, stage ii inverted papilloma of the paranasal sinus and nasal cavity, stage ii lymphoepithelioma of the nasopharynx, stage ii lymphoepithelioma of the oropharynx, stage ii midline lethal granuloma of the paranasal sinus and nasal cavity, stage ii mucoepidermoid carcinoma of the oral cavity, stage ii papillary thyroid cancer, stage ii salivary gland cancer, stage ii squamous cell carcinoma of the hypopharynx, stage ii squamous cell carcinoma of the larynx, stage ii squamous cell carcinoma of the lip and oral cavity, stage ii squamous cell carcinoma of the oropharynx, stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity, stage ii verrucous carcinoma of the larynx, stage ii verrucous carcinoma of the oral cavity